Antibody-based protein depletion column

Monday, 06 April, 2009 | Supplied by: Merck


The Seppro IgY depletion platform is an antibody-based technology for processing plasma, serum and plant samples. It enables researchers to detect and analyse commonly obscured biomarkers in samples by removing highly abundant proteins.

The products are built using chicken-derived IgY antibodies, providing selectivity and low cross-reactivity. The Seppro platform removes 14 of the most abundant proteins from human serum or plasma, as well as other high and medium abundant proteins.

Additional products are available for the depletion of mouse and rat samples, as well as the removal of Rubisco.

The platform is complemented by a library of 700 polyclonal IgY antibodies, derived from chicken embryos and prepared using recombinant antigens.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system

The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...

Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit

The kit includes a comprehensive set of optimised screening reagents and conditions that...

Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit

The kit enables simultaneous detection, discrimination and absolute quantification of seven known...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd